| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 58321* | 2013 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 29090* | 2016 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 8621* | 2005 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7351 | 2015 |
| From local explanations to global understanding with explainable AI for trees SM Lundberg, G Erion, H Chen, A DeGrave, JM Prutkin, B Nair, R Katz, ... Nature machine intelligence 2 (1), 56-67, 2020 | 5584 | 2020 |
| US renal data system 2016 annual data report: epidemiology of kidney disease in the United States R Saran, B Robinson, KC Abbott, LYC Agodoa, P Albertus, J Ayanian, ... American journal of kidney diseases 69 (3), A7-A8, 2017 | 3801 | 2017 |
| Cystatin C and the risk of death and cardiovascular events among elderly persons MG Shlipak, MJ Sarnak, R Katz, LF Fried, SL Seliger, AB Newman, ... New England Journal of Medicine 352 (20), 2049-2060, 2005 | 1651 | 2005 |
| New loci associated with kidney function and chronic kidney disease A Köttgen, C Pattaro, CA Böger, C Fuchsberger, M Olden, NL Glazer, ... Nature genetics 42 (5), 376-384, 2010 | 1379* | 2010 |
| Cystatin C versus creatinine in determining risk based on kidney function MG Shlipak, K Matsushita, J Ärnlöv, LA Inker, R Katz, KR Polkinghorne, ... New England Journal of Medicine 369 (10), 932-943, 2013 | 1061 | 2013 |
| Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts RT Gansevoort, K Matsushita, M Van Der Velde, BC Astor, M Woodward, ... Kidney international 80 (1), 93-104, 2011 | 902 | 2011 |
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease MG Shlipak, R Katz, MJ Sarnak, LF Fried, AB Newman, C Stehman-Breen, ... Annals of internal medicine 145 (4), 237-246, 2006 | 785 | 2006 |
| Age and association of kidney measures with mortality and end-stage renal disease SI Hallan, K Matsushita, Y Sang, BK Mahmoodi, C Black, A Ishani, ... Jama 308 (22), 2349-2360, 2012 | 731 | 2012 |
| A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study NA Zakai, R Katz, C Hirsch, MG Shlipak, PHM Chaves, AB Newman, ... Archives of internal medicine 165 (19), 2214-2220, 2005 | 622 | 2005 |
| Relationship of uric acid with progression of kidney disease M Chonchol, MG Shlipak, R Katz, MJ Sarnak, AB Newman, DS Siscovick, ... American Journal of Kidney Diseases 50 (2), 239-247, 2007 | 542 | 2007 |
| Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function C Pattaro, A Teumer, M Gorski, AY Chu, M Li, V Mijatovic, M Garnaas, ... Nature communications 7 (1), 10023, 2016 | 522 | 2016 |
| Cystatin C concentration as a risk factor for heart failure in older adults MJ Sarnak, R Katz, CO Stehman-Breen, LF Fried, NS Jenny, BM Psaty, ... Annals of internal medicine 142 (7), 497-505, 2005 | 487 | 2005 |
| Rapid kidney function decline and mortality risk in older adults DE Rifkin, MG Shlipak, R Katz, LF Fried, D Siscovick, M Chonchol, ... Archives of internal medicine 168 (20), 2212-2218, 2008 | 420 | 2008 |
| Explainable AI for trees: From local explanations to global understanding SM Lundberg, G Erion, H Chen, A DeGrave, JM Prutkin, B Nair, R Katz, ... arXiv preprint arXiv:1905.04610, 2019 | 411 | 2019 |
| Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study AM O’Hare, R Katz, MG Shlipak, M Cushman, AB Newman Circulation 113 (3), 388-393, 2006 | 406 | 2006 |
| Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study) JH Ix, R Katz, BR Kestenbaum, IH de Boer, M Chonchol, KJ Mukamal, ... Journal of the American College of Cardiology 60 (3), 200-207, 2012 | 403 | 2012 |